Invesco Pharmaceuticals ETF Rating $85.66 +0.98 (+1.16%) (As of 01:48 PM ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatings Invesco Pharmaceuticals ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PJP Aggregate RatingModerate Buy 2.67Holdings in PJP have an aggregate rating of Moderate Buy based on 320 analyst ratings issued in the past year covering 25 companies (99.9% of the portfolio).PJP Aggregate Price Target$85.49-0.20% DownsideHigh Prediction$85.49Average Prediction$85.49Low Prediction$85.49Holdings in PJP have an aggregate price target of $85.49 and a range of $85.49 to $85.49 covering 25 companies (99.9% of the portfolio).PJP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 PJP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.87%ABTAbbott Laboratories$116.93+0.9%4.971 of 5 stars2.75$130.07 11.2%16Positive News5.77%ABBVAbbVie$172.00+2.5%4.9638 of 5 stars2.90$203.37 18.2%21Analyst ForecastPositive News5.48%JNJJohnson & Johnson$155.44+1.5%4.966 of 5 stars2.53$175.94 13.2%15Positive News5.47%AMGNAmgen$290.14+0.8%4.9132 of 5 stars2.46$333.57 15.0%26Ex-DividendShort Interest ↓Positive News5.43%PFEPfizer$25.07+0.5%5 of 5 stars2.50$32.92 31.3%16Analyst DowngradeAnalyst RevisionNews Coverage4.93%MRKMerck & Co., Inc.$99.38+2.0%4.9964 of 5 stars2.68$130.86 31.7%19Dividend IncreasePositive News4.81%CORTCorcept Therapeutics$56.12+0.1%4.7045 of 5 stars3.00$65.25 16.3%5Positive News4.76%LLYEli Lilly and Company$749.34-0.5%4.9913 of 5 stars2.81$1,007.94 34.5%21Analyst Revision3.89%REGNRegeneron Pharmaceuticals$752.85+1.3%4.8024 of 5 stars2.78$1,099.55 46.1%23Positive News3.88%GILDGilead Sciences$89.56+1.0%4.6461 of 5 stars2.65$94.45 5.5%26Analyst UpgradePositive News3.83%BMYBristol-Myers Squibb$58.23+0.6%4.7863 of 5 stars2.20$54.07 -7.1%20Analyst Revision3.78%PCRXPacira BioSciences$17.49+2.7%4.0043 of 5 stars2.20$23.50 34.4%10Positive News3.59%UTHRUnited Therapeutics$369.24+1.3%4.5228 of 5 stars2.73$370.86 0.4%15Analyst RevisionPositive News3.47%AMPHAmphastar Pharmaceuticals$44.58+1.1%4.7356 of 5 stars2.67$63.00 41.3%33.45%LGNDLigand Pharmaceuticals$117.79+5.6%4.9348 of 5 stars3.00$144.83 23.0%63.38%PBHPrestige Consumer Healthcare$83.73+1.3%3.6017 of 5 stars2.67$83.67 -0.1%33.37%INVAInnoviva$19.26+0.6%1.3021 of 5 stars3.001News Coverage3.31%SUPNSupernus Pharmaceuticals$36.110.0%2.3422 of 5 stars2.50$36.00 -0.3%2Positive News3.30%AMRXAmneal Pharmaceuticals$8.38-0.4%3.2167 of 5 stars2.80$10.00 19.3%5Insider Trade3.26%VTRSViatris$13.26+1.0%1.3601 of 5 stars2.00$13.33 0.6%33.17%JAZZJazz Pharmaceuticals$125.08+4.9%4.9239 of 5 stars2.80$175.33 40.2%15Analyst ForecastGap Up3.03%GERNGeron$4.03+1.0%3.5335 of 5 stars3.00$7.05 74.9%112.95%ANIPANI Pharmaceuticals$56.27+2.1%4.3472 of 5 stars2.83$77.33 37.4%6Positive News2.89%PRGOPerrigo$27.25+0.4%4.9834 of 5 stars2.75$37.00 35.8%4News CoveragePositive News2.84%BIIBBiogen$157.89+1.2%4.8648 of 5 stars2.54$257.20 62.9%28Analyst Downgrade This page (NYSEARCA:PJP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
